SHARE研究——头颈癌幸存者:评估加拿大安大略省患者照护与随访依从性的随机对照试验研究方案
本研究为前瞻性、单中心、双臂、优效性随机对照试验,计划纳入252例头颈癌幸存者,按1:1随机分配至干预组(治疗总结与幸存者照护计划及一次动机性访谈)或对照组(仅常规照护),评估12个月时初级保健提供者处理患者自报幸存者症状/关切的比例等结局。
要点
- 干预为45分钟动机性访谈,由受训执业护士实施,聚焦前3项幸存者症状/关切。
- 主要结局为12个月时初级保健提供者处理患者自报症状/关切的比例。
- 次要结局包括患者满意度、生活质量及初级保健提供者对治疗总结与幸存者照护计划实用性的反馈。
核心结论
- 本研究将为将可扩展的治疗总结与幸存者照护计划及动机性访谈联合干预整合入常规头颈癌幸存者照护的可行性与有效性提供新证据。
研究设计与样本
- 前瞻性、单中心、双臂、优效性随机对照试验,1:1分配,计划纳入252例头颈癌幸存者。
- 纳入标准:I-IVA期、年龄≥18岁、根治性治疗后3-6个月、英语使用者、无转移或残留病灶。
- 通过加拿大伦敦维多利亚医院幸存者门诊由受训研究助理招募,招募于2025年5月开始。
- 结局在基线、基线访视后3、6、12个月评估。
- 采用意向性治疗分析,混合效应模型评估组间随时间差异。
主要发现
- 主要结局为12个月时初级保健提供者处理患者自报幸存者症状/关切的比例,组间比较。
- 次要结局包括患者对治疗总结与幸存者照护计划及动机性访谈的满意度、对照护与信息的满意度、生活质量及初级保健提供者对治疗总结与幸存者照护计划实用性的反馈。
关键数值与推荐
- 干预组接受治疗总结与幸存者照护计划及一次45分钟动机性访谈,由受训执业护士实施。
- 动机性访谈聚焦探索前3项患者幸存者症状/关切,提供资源与转诊,并设定与幸存者照护建议相关的目标。
- 对照组仅接受常规照护。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Survivors of head and neck cancer (HNC) experience long-term physical and psychosocial effects post-treatment, however, often receive fragmented survivorship care. Evidence-based survivorship guidelines exist, but implementation remains limited. Poor coordination, insufficient communication, and lack of tailored support contribute to unmet patient needs. Treatment Summary and Survivorship Care Plans (TSSP) and Motivational Interviewing (MI) may improve self-efficacy and adherence to survivorship care recommendations. This study aims to evaluate whether a personalized TSSP along with a one-time MI counselling session improves physician implementation of survivorship care recommendations, patient satisfaction with post-treatment care, and quality of life (QoL) among HNC survivors. METHODS/DESIGN: This study is a prospective, single-centre, two-arm, superiority randomized controlled trial (RCT) with a 1:1 allocation ratio. Outcomes will be evaluated at baseline, 3, 6, and 12 months post-baseline visit. A total of 252 HNC survivors (stage I-IVA, aged ≥ 18 years, 3-6 months post-definitive treatment, English-speaking, with no metastatic or residual disease) will be recruited by a trained research assistant through the Survivorship Clinic at Victoria Hospital in London, Canada. Recruitment began in May 2025. Participants will be randomized to either the intervention group (TSSP and MI session) or the control group (usual care only). The intervention consists of a 45-min MI session delivered by a trained nurse practitioner, focused on exploring the top 3 patient survivorship symptoms/concerns, providing resources and referrals, and goal-setting related to survivorship care recommendations. The primary outcome is the proportion of patient-identified survivorship symptoms/concerns addressed by primary care providers (PCP) at 12 months post-baseline between study groups, with secondary assessments at 3 and 6 months. Secondary outcomes include patient satisfaction with the TSSP and MI session, patient satisfaction with care and information, QoL, and PCP feedback on the utility of the TSSP. Descriptive statistics will be reported, and intention-to-treat analyses will be conducted using mixed-effects models to evaluate group differences over time. DISCUSSION: This study will contribute new evidence on the feasibility and effectiveness of integrating a scalable, combined TSSP and MI counselling intervention into routine HNC survivorship care. By promoting patient-centered communication, this approach may empower survivors to engage in self-management and improve long-term health outcomes. Findings will inform best practices for survivorship care planning and support the implementation of patient-tailored interventions across various oncology settings. TRIAL REGISTRATION: ClinicalTrials.gov NCT06127784. Registered on Nov. 6, 2023; https://www. CLINICALTRIALS: gov/study/NCT06127784 .
引用
- Tran B, Dzioba A, Baker J, et al. The SHARE study - Survivorship After Head and Neck Cancer: evaluating patient care and adherence to follow up in Ontario, Canada: study protocol for a randomized controlled trial. Trials. 2025. PMID: 41390453. doi:10.1186/s13063-025-09332-5
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。